SDF peer researchers with lived and living experience conducted interviews with 46 people accessing LAIB in the community from across the four health boards. Approximately half (52%, n=24) were male and the other half were female (48%, n=22). Participants reported the length of time accessing LAIB treatment, ranging from less than three months to over two years.
A further nine prison residents shared their experience of LAIB in custodial and community settings, over three focus groups held at HMP Inverness and HMP Dumfries & Galloway; all nine participants were male. Eight of these were currently prescribed LAIB and one was currently prescribed Espranor but had previously received LAIB.
53 staff completed online surveys about their experiences of supporting individuals on LAIB, which included 39 NHS staff and 14 working in third sector or voluntary services.
Listen to SDF’s Drugs Uncut podcast below, to learn more about the research design process, and SDF’s peer research approach which involves people with lived and living experience in research design and data collection: